论文信息 - Safe switch to β-interferon treatment of chronic hepatitis C after α-interferon-induced autoimmune thrombocytopenia - 字舞流文

Safe switch to β-interferon treatment of chronic hepatitis C after α-interferon-induced autoimmune thrombocytopenia

F. Negro | A. Hadengue | A. Angeli | G. Tappero | M. Gallo | M. Farina

[1] L. Platanias,et al. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. , 1994, The Journal of biological chemistry.

[2] M. Revel,et al. The human interferon α-receptor protein confers differential responses to human interferon-β versus interferon-α subtypes in mouse and hamster cell transfectants , 1994 .

[3] T. Ishikawa,et al. A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. , 1993, Gastroenterology.

[4] W. Yung,et al. Growth Inhibitory Effects of Interferon-β but Not Interferon-α on Human Glioma Cells: Correlation of Receptor Binding, 2′,5′-O1igoadenylate Synthetase and Protein Kinase Activity , 1990 .

[5] F. Negro,et al. Interferon-induced "lupoid" thrombocytopenia in chronic hepatitis C. , 1996, Journal of hepatology.

[6] R. Michalevicz,et al. Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha. , 1988, Leukemia research.

[7] P. Lengyel. Biochemistry of interferons and their actions. , 1982, Annual review of biochemistry.